Akso Health Group
AHG
$1.33
-$0.02-1.48%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 675.98% | 675.98% | 14.83% | 14.83% | -92.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 675.98% | 675.98% | 14.83% | 14.83% | -92.46% |
| Cost of Revenue | 688.65% | 688.65% | 21.67% | 21.67% | -92.03% |
| Gross Profit | 396.91% | 396.91% | -41.76% | -41.76% | -96.55% |
| SG&A Expenses | -68.85% | -68.85% | -54.86% | -54.86% | 74.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 132.91% | 132.91% | -48.98% | -48.98% | -73.43% |
| Operating Income | 76.65% | 76.65% | 54.99% | 54.99% | -951.68% |
| Income Before Tax | 83.08% | 83.08% | 58.89% | 58.89% | -283.20% |
| Income Tax Expenses | 57.26% | 57.26% | -96.55% | -96.55% | 110.17% |
| Earnings from Continuing Operations | 81.96% | 81.96% | 58.91% | 58.91% | -286.03% |
| Earnings from Discontinued Operations | -- | -- | -100.05% | -100.05% | 52.05% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5,533.33% | -5,533.33% | 160.58% | 160.58% | 96.25% |
| Net Income | 83.03% | 83.03% | -176.53% | -176.53% | -526.65% |
| EBIT | 76.65% | 76.65% | 54.99% | 54.99% | -951.68% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 98.28% | 98.28% | 11.58% | 11.58% | -527.12% |
| Normalized Basic EPS | 98.07% | 98.07% | 87.16% | 87.16% | -286.10% |
| EPS Diluted | 98.28% | 98.28% | 14.41% | 14.41% | -604.00% |
| Normalized Diluted EPS | 98.07% | 98.07% | 87.16% | 87.16% | -286.10% |
| Average Basic Shares Outstanding | 919.05% | 919.05% | 212.60% | 212.60% | 0.00% |
| Average Diluted Shares Outstanding | 919.05% | 919.05% | 212.60% | 212.60% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |